ME1 watching -Mernova Medicinal Inc. (“Mernova”) has recorded...

ME1 watching -
Mernova Medicinal Inc. (“Mernova”) has recorded strong sales revenue and confirmed purchase
orders (POs) in the September quarter to-date (approximately half a quarter) of $1.3 m1
(CA$1.135m);
Mernova on track to again achieve significant quarter on quarter growth, with Q3 revenue to date
of $1.3m only half way through the quarter, compared to Q2 full quarter revenue of $1.5m;